Mati Therapeutics
Developer of a novel, non-invasive sustained drug delivery platform designed to deliver medication to the surface of the eye for improved treatment of ocular conditions. The company's platform offers ...
Valuation
—
Share Price
N/A
Total Raised
$13.7M
Last Round
N/A
Valuation History
0 funding rounds on record
Cap Table
Ownership structure
Market Activity
Secondary transactions
Company Details
Sector
Healthcare
Headquarters
Austin, TX, United States
Founded
2012
Employees
10
Website
matitherapeutics.com